California’s Gilead, Israel’s Teva settle patent row over HIV drug
A California pharmaceutical company has settled its patent dispute with a rival drugmaker over a treatment for HIV and Hepatitis B. News of the settlement adjourns a trial that was to start on Feb. 20.Gilead Sciences, Inc., which is headquartered in Foster City, sued...